A new study has shown that once-weekly oral bisphosphonate can prevent and improve bone loss in men undergoing androgen deprivation therapy (ADT ... mass at baseline. After 1 year, men who ...
screening when ADT is prescribed, addressing a long-standing gap in surveillance of bone health. After its adoption, rates of DXA screening increased from 9.5% to 33.6% (P <.001), highlighting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback